Prevalência de trombose coronariana após angioplastia primária em pacientes com infarto agudo de miocárdio e COVID-19: uma revisão bibliográfica
DOI:
https://doi.org/10.11606/issn.1679-9836.v102i2e-195948Palavras-chave:
COVID-19, SARS-CoV-2, Angioplastia, Trombose, InfartoResumo
Introdução: A COVID-19 é causada pelo coronavírus da síndrome respiratória aguda grave (SARS-CoV-2) e os indivíduos com maior probabilidade de apresentarem sintomas mais graves são idosos com comorbidades como: diabetes, doenças cardiovasculares, câncer e histórico de tabagismo. Esta doença cursa com liberação de mediadores inflamatórios e ateroscleróticos, gerando a instalação do estado hipercoagulável, o que levanta a possibilidade de risco aumentado para síndromes coronárias agudas e trombose coronariana pós angioplastia primária. Objetivo: Avaliar a prevalência de trombose coronariana após angioplastia primária em pacientes com infarto agudo de miocárdio infectados pela COVID-19. Material e métodos: Trata-se de uma pesquisa bibliográfica do tipo revisão de literatura tendo como base produções científi-cas publicadas nas seguintes bases de dados: PubMed, Medline, SciELO, NCBI e Lilacs. Resultados: Quanto a técnica de revascularização a ser escolhida temos que, a angioplastia primária é utilizada como principal estratégia para redução de danos, melhor desfecho e preservação da função ventricular, na doença cardíaca isquêmica aguda. Entretanto, a incidência de eventos tromboembólicos é extremamente alta em pacientes com infarto agudo do miocárdio com supra de ST infectados com o SARS-Cov-2 submetidos à angioplastia primária, de acordo com alguns estudos. Conclusão: Há maior prevalência de trombose coronariana em pacientes com infarto agudo do miocárdio com supra de ST infectados com o SARS-Cov-2 após serem submetidos à angioplastia primária.
Downloads
Referências
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-260. doi: 10.1038/s41569-020-0360-5.
Massa KHC, Duarte YAO, Chiavegatto Filho ADP. Análise da prevalência de doenças cardiovasculares e fatores associados em idosos, 2000-2010. Cien Saude Colet. 2019;24(1):105-114. https://doi.org/10.1590/1413-81232018241.02072017.
Martins JDN, Sardinha DM, da Silva RR, Lima KVB, Lima LNGC. Implications of COVID-19 on the cardiovascular system: prognosis and intercurrences. J Health Biol Sci. 2020;8(1):1-9. http://dx.doi.org/10.12662/2317-3076jhbs.v8i1.3355.p1-9.2020.
Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myo-cardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351(25):2611-8. doi: 10.1056/NEJMoa041747.
Ayan M, Kovelamudi S, Al-Hawwas M. Subacute stent thrombosis in a patient with COVID-19 pneumonia. Proc (Bayl Univ Med Cent). 2021;34(1):175-177. doi: 10.1080/08998280.2020.1812792.
Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-147. doi: 10.1016/j.thromres.2020.04.013.
Warren-Gash C, Blackburn R, Whitaker H, McMenamin J, Hayward AC. Laborato-ry-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scot-land. Eur Respir J. 2018;51(3):1701794. doi: 10.1183/13993003.01794-2017.
Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378(4):345-353. doi: 10.1056/NEJMoa1702090.
Vicente MBA, Dopico RR, Domingos LML, Peralta TCM, Manuel V, Martinez JCE, et al. Primary angioplasty in acute myocardial infarction: initial experience in a developing country. J Transcat Intervent. 2021;29eA202105.
Nomura S, Taniura T, Ito T. Extracellular vesicle-related thrombosis in viral infection. Int J Gen Med. 2020;13:559-568. doi: 10.2147/IJGM.S265865.
AHA/ASA Stroke Council Leadership. Temporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease 2019 (COVID-19) Pandemic: On Behalf of the American Heart Association/American Stroke Association Stroke Council Leadership. Stroke. 2020;51(6):1910-1912. doi: 10.1161/STROKEAHA.120.030023.
Rassam E, Pinheiro TC, Stefan LFB, Módena SF. Thromboembolic complications in surgical patients and its prophylaxis. ABCD Arq Bras Cir Dig 2009;22(1):41-4
Beun R, Kusadasi N, Sikma M, Westerink J, Huisman A. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2. Int J Lab Hematol. 2020;42(Suppl 1):19-20. http://dx.doi.org/10.1111/ijlh.13230 PMid:32311843.
Bermejo-Martin JF, Martín-Fernandez M, López-Mestanza C, Duque P, Almansa R. Shared features of endothelial dysfunction between sepsis and its preceding risk factors (aging and chronic disease). J Clin Med. 2018;7(11):400. doi: 10.3390/jcm7110400.
Bermejo-Martin JF, Almansa R, Torres A, González-Rivera M, Kelvin DJ. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction. Cardiovasc Res. 2020;116(10):e132-e133. http://dx.doi.org/10.1093/cvr/cvaa140. PMid:32420587.
Brandão SCS, Godoi ETAM, Ramos JOX, Melo LMMP, Sarinho ESC. COVID-19 grave: entenda o papel da imunidade, do endotélio e da coagulação na prática clínica. J Vasc Bras. 2020;19:e20200131.
Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020;20(10):1135-40 doi:10.1016/s1473-3099(20)30434-5
Neumann FJ, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, et al. Induction of Cytokine Expression in Leukocytes by Binding of Thrombin-Stimulated Platelets. Circulation. 1997;95(10):2387-94. https://doi.org/ 10.1161/01.CIR.95.10.2387.
Guo L, Rondina MT. The Era of Thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases. Front Immunol. 2019;10:2204. doi: 10.3389/fimmu.2019.02204.
Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362. doi:10.1016/j.jcv.2020.104362
Lippi G, Plebani M, Henry BM, Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145-8. doi: 10.1016/j.cca.2020.03.022.
Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004;109(22):2698e704 doi: 10.1161/01.CIR.0000131660.51520.9A.
Briscoe M, Sykes R, Krystofiak T, Peck O, Mangion K, Berry C. Clinical signifi-cance of coronavirus disease 2019 in hospitalized patients with myocardial injury. Clin Cardiol. 2021;44(3):332-339.
Smilowitz NR, Subashchandran V, Yuriditsky E, Horowitz JM, Reynolds HR, Hochman JS, et al. Thrombosis in hospitalized patients with viral respiratory infec-tions versus COVID-19. Am Heart J. 2021;231:93-95. doi: 10.1016/j.ahj.2020.10.075.
Choi S, Jang WJ, Song YB, Lima JAC, Guallar E, Choe YH, et al. D-Dimer Levels Predict Myocardial Injury in ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study. PLoS One. 2016;11(8):e0160955. doi: 10.1371/journal.pone.0160955.
Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, et al. ST- seg-ment elevation in patients with Covid-19 - a case series. N Engl J Med. 2020;382:2478-80. doi: 10.1056/NEJMc2009020.
Satturwar S, Fowkes M, Farver C, Wilson AM, Eccher A, Girolami I, et al. Post-motem Findings Associated With SARS-CoV-2: systematic review and meta-analysis. Am J Surg Pathol. 2021;45(5):587-603. doi: 10.1097/PAS.0000000000001650.
Chew NW, Sia CH, Wee HL, Da Benedict LJ, Rastogi S, Kojodjojo P, et al. Impact of the COVID-19 Pandemic on Door-to-Balloon Time for Primary Percutaneous Coronary Intervention - results from the Singapore Western STEMI Network. Circ J. 2021;85(2):139-149. doi: 10.1253/circj.CJ-20-0800.
Choudry FA, Hamshere SM, Rathod KS, Akhtar M, Archbold RA, Guttmann OP, et al. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2020;76(10):1168-1176. doi: 10.1016/j.jacc.2020.07.022.
Lacour T, Semaan C, Genet T, Ivanes F. Insights for increased risk of failed fibrino-lytic therapy and stent thrombosis associated with COVID-19 in ST-segment eleva-tion myocardial infarction patients. Catheter Cardiovasc Interv. 2021;97(2):E241-E243. doi: 10.1002/ccd.28948.
Kaur S, Bansal R, Kollimuttathuillam S, Gowda AM, Singh B, Mehta D, et al. The looming storm: Blood and cytokines in COVID-19. Blood Rev. 2021;46:100743. doi: 10.1016/j.blre.2020.100743.
Avila J, Long B, Holladay D, Gottlieb M. Thrombotic complications of COVID-19. Am J Emerg Med. 2021;39:213-218. doi: 10.1016/j.ajem.2020.09.065.
Keskin G, Uysal A, Erturk E, Hafız E, Dogan OF. Urgent Percutaneous Coronary Artery Intervention and Coronary Artery Bypass Grafting in STEMI Patients with Confirmed COVID-19. Heart Surg Forum. 2021;24(3):E564-E574. doi: 10.1532/hsf.3567.
Purroy F, Arqué G. Influence of thromboembolic events in the prognosis of COVID-19 hospitalized patients. Results from a cross sectional study. PLoS One. 2021;16(6):e0252351. doi: 10.1371/journal.pone.0252351.
Fayol A, Livrozet M, Boutouyrie P, Khettab H, Betton M, Tea V, et al. Cardiac per-formance in patients hospitalized with COVID-19: a 6 month follow-up study. ESC Heart Fail. 2021;8(3):2232-2239. doi: 10.1002/ehf2.13315.
Erdinc B, Sahni S, Gotlieb V. Hematological manifestations and complications of COVID-19. Adv Clin Exp Med. 2021;30(1):101-107. doi: 10.17219/acem/130604.
Violi F, Pastori D, Pignatelli P, Cangemi R. SARS-CoV-2 and myocardial injury: a role for Nox2?. Intern Emerg Med. 2020;15(5):755-758. doi: 10.1007/s11739-020-02348-6.
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-8. doi: 10.1007/s00134-020-05991-x.
Torres-Escobar G, González-PachecO H, Briseño-De la Cruz JL, Arias-Mendoza A, Araiza-Garaygordobil D. Impact of COVID-19 on reperfusion strategies for acute coro-nary syndromes. Cardiovasc Metab Sci. 2020;90(Supl):62-66. doi: 10.24875/ACM.M20000069.
Lima GC, Junior JM, Chierice JRA, Filho MOL. Intervenções coronarianas percutâneas durante a pandemia de Covid-19. Rev Soc Cardiol Estado São Paulo. 2020;30(4):472-8. https://doi.org/10.36660/abc.20190653.
Rahman N, Ullah I, Adnan G. Streptokinase in a COVID-19-positive patient with STEMI in a PPCI centre: a local experience. BMJ Case Rep. 2021;14:e239068. doi: 10.1136/bcr-2020-239068.
Abizaid A, Caixeta AM. Intervenção coronariana percutânea de resgate após fibrinólise. Arq Bras Cardiol. 2004;82(5):411-2. https://doi.org/10.1590/S0066-782X2004000500003
The GUSTO angiographic investigators. The effect of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med. 1993;329(22):1615-22. doi: 10.1056/NEJM199311253292204.
Stefanini GG, Montorfano M, Trabattoni D, Andreini D, Ferrante G, Ancona M, et al. ST-elevation myocardial infarction in patients with COVID-19: clinical and angio-graphic outcomes. Circulation. 2020;141(25):2113–6. doi: 10.1161/CIRCULATIONAHA.120.047525.
Sianos G, Papafaklis MI, Serruys PW. Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol. 2010;22(10 Suppl B):6B–14B.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2023 Sandy Parreira Agostinete, Clara Pechmann Mendonça El Sabbagh, Adriana Boiteux do Carmo, Marcelo Luiz Peixoto Sobral
Este trabalho está licenciado sob uma licença Creative Commons Attribution-ShareAlike 4.0 International License.
